These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 15653205

  • 1. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb 01; 118(2):209-13. PubMed ID: 15653205
    [Abstract] [Full Text] [Related]

  • 2. [Combined use of metformin and Diane35 in polycystic ovary syndrome].
    Mitkov M, Pekhlivanov B, Terzieva D.
    Akush Ginekol (Sofiia); 2004 Feb 01; 43(3):34-7. PubMed ID: 15341255
    [Abstract] [Full Text] [Related]

  • 3. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):93-8. PubMed ID: 16360262
    [Abstract] [Full Text] [Related]

  • 4. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul 01; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 5. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL, Yang HY, Zhao JZ, Lin JJ, Lin WQ.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec 01; 38(12):745-8. PubMed ID: 14728846
    [Abstract] [Full Text] [Related]

  • 6. Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.
    Kebapcilar L, Kebapcilar AG, Bilgir O, Taner CE, Bozkaya G, Yildiz Y, Sari I.
    Gynecol Endocrinol; 2011 Feb 01; 27(2):91-5. PubMed ID: 20528207
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.
    Fertil Steril; 2004 Oct 01; 82(4):893-902. PubMed ID: 15482765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2009 Apr 01; 14(2):153-9. PubMed ID: 19340711
    [Abstract] [Full Text] [Related]

  • 11. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.
    Gynecol Endocrinol; 2002 Jun 01; 16(3):217-24. PubMed ID: 12192894
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
    Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Martínez-Bermejo E, Lasunción MA, Escobar-Morreale HF.
    J Clin Endocrinol Metab; 2007 Jul 01; 92(7):2453-61. PubMed ID: 17426085
    [Abstract] [Full Text] [Related]

  • 14. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D, Georgopoulos NA, Piouka A, Katsikis I, Saltamavros AD, Decavalas G, Diamanti-Kandarakis E.
    Gynecol Endocrinol; 2011 Aug 01; 27(8):587-92. PubMed ID: 20836726
    [Abstract] [Full Text] [Related]

  • 15. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S, Quadbeck B, Elsenbruch S, Gärtner R, Finke R, Mann K, Janssen OE.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1059-64. PubMed ID: 15136950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
    Orbetsova M, Kamenov Z, Kolarov G, Zakharieva S, Khristov V, Atanasova I, Shigarminova R, Milcheva B, Genchev G.
    Akush Ginekol (Sofiia); 2006 May 07; 45(7):16-28. PubMed ID: 17489164
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
    Liu ZA, Xue YM, Chen LX, Cai Q, Chen H, Zhang J, Cui QH, Ge J, Yuan T.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep 07; 39(9):586-90. PubMed ID: 15498183
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM, Jha A.
    Fertil Steril; 2012 Oct 07; 98(4):1053-9. PubMed ID: 22795636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.